Prognostic value of inflammatory markers in patients with COVID-19 in Indonesia.

ABSTRACT:

Background & aims

Coronavirus disease 2019 (COVID-19) has a wide clinical spectrum, ranging from asymptomatic infection to severe diseases with high mortality rate. Early identification of high-risk COVID-19 patients may be beneficial to reduce morbidity and in-hospital mortality. This study aimed to investigate whether baseline levels of inflammatory markers such as C-reactive protein (CRP) and immune-cell-based inflammatory indices, neutrophil to lymphocyte ratio (NLR), derived-NLR (d-NLR), and platelet to lymphocyte ratio (PLR) at hospital admission are associated with adverse disease outcomes in COVID-19 patients.

Methods

Clinical data from 391 hospitalized COVID-19 patients in three Siloam Hospitals in Indonesia were retrospectively collected and analysed from March 20

SUBMITTER: Prasetya IB 

PROVIDER: S-EPMC8186126 | biostudies-literature | 2021 Jul-Sep

REPOSITORIES: biostudies-literature